We just need Leronlimab approval for the combo, until then we will have interim results for mTNBC, and off-label use will no longer be able to stop, it will be a market-approved drug that has long been tested without serious side effects and if proven to have metastatic effects, Leronlimab will simply become a massively used drug next year. It's a special set of circumstances, to get Leronlimab approved for a combo, and at the same time to prove it works on metastases and then with so many cancers, it's incredible what the potential is.